# COVID-19: NIAID CLINICAL SITE MONITORING

> **NIH NIH N01** · PPD DEVELOPMENT LP · 2022 · $912,600

## Abstract

The purpose of the Clinical Site Monitoring contract is to provide comprehensive clinical site and study monitoring services for the NIAID clinical trial research portfolio, including the delivery of monitoring services for unanticipated NIAID clinical research projects that may be required in response to emerging needs or public health emergencies. This project will provide clinical trial monitoring services for the COVID-19 clinical trial ACTIV-2 (Outpatient Monoclonal Antibodies And Other Therapies).

## Key facts

- **NIH application ID:** 10687948
- **Project number:** 272201700004C-P00010-9999-2
- **Recipient organization:** PPD DEVELOPMENT LP
- **Principal Investigator:** KIMBERLY SMITH
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $912,600
- **Award type:** —
- **Project period:** 2022-02-01 → 2023-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10687948

## Citation

> US National Institutes of Health, RePORTER application 10687948, COVID-19: NIAID CLINICAL SITE MONITORING (272201700004C-P00010-9999-2). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10687948. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*